.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The CONCEPTT trial randomized pregnant women with type 1 diabetes to real-time continuous glucose monitoring plus standard care or standard care alone. CGM use improved time spent in the target glucose range, reduced hyperglycemia, and was associated with better neonatal outcomes including lower rates of large-for-gestational-age birth and neonatal intensive care admission. For maternal-fetal medicine teams, the trial demonstrates that diabetes technology can be clinically meaningful in pregnancy when patients are trained to respond to trend information. The benefit is not simply the number of glucose readings but the ability to identify excursions and adjust insulin and nutrition in near real time. Implementation requires education, device access and rapid clinician feedback. The study supports a multidisciplinary model involving obstetrics, diabetology and diabetes educators, particularly for women at high risk of fetal overgrowth or glycemic instability.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The CONCEPTT trial randomized pregnant women with type 1 diabetes to real-time continuous glucose monitoring plus standard care or standard care alone. CGM use improved time spent in the target glucose range, reduced hyperglycemia, and was associated with better neonatal outcomes including lower rates of large-for-gestational-age birth and neonatal intensive care admission. For maternal-fetal medicine teams, the trial demonstrates that diabetes technology can be clinically meaningful in pregnancy when patients are trained to respond to trend information. The benefit is not simply the number of glucose readings but the ability to identify excursions and adjust insulin and nutrition in near real time. Implementation requires education, device access and rapid clinician feedback. The study supports a multidisciplinary model involving obstetrics, diabetology and diabetes educators, particularly for women at high risk of fetal overgrowth or glycemic instability.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
